Results and challenges of immune checkpoint inhibitors in colorectal cancer-Reference-Cited by-同舟云学术

Results and challenges of immune checkpoint inhibitors in colorectal cancer

Published:2018-02-28 Issue:5 Volume:18 Page:561-573
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Emambux Sheik¹^ORCID,Tachon Gaelle²³⁴,Junca Audelaure⁴⁵,Tougeron David¹⁴⁶^ORCID

Affiliation:

1. Department of Medical Oncology, Poitiers University Hospital, Poitiers, France

2. Department of Cancer biology, Poitiers University Hospital, Poitiers, France

3. INSERM U-1084, Experimental and Clinical Neurosciences Laboratory, Cellular Therapies in Brain Diseases group, University of Poitiers, Poitiers, France

4. University of Poitiers, Faculty of medicine, Poitiers France

5. Department of Pathology, Poitiers University Hospital, Poitiers, France

6. Department of Gastroenterology, Poitiers University Hospital, Poitiers, France

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1445222

Reference102 articles.

1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

2. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

3. Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients

4. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

5. Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of CD8+ T-cells in colorectal cancer immunotherapy;Heliyon;2024-06

2. Genetically predicted Vascular endothelial growth factor A mediates the association between CD3+ CD8+ TD T cell and Colorectal cancer: A Mendelian randomization analysis;2024-02-20

3. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress;International Immunopharmacology;2024-01

4. Association between Metabolic Reprogramming and Immune Regulation in Digestive Tract Tumors;Oncology Research and Treatment;2024

5. Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status;Russian Journal of Archive of Patology;2024